Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Example of PR for Proof Of Concept

<< Previous

Bullboard Posts

Next >>

Comment by Biobobon Oct 24, 2022 11:03am

76 Views

Post# 35043586

RE:RE:RE:Example of PR for Proof Of Concept

Wel then it is great news that she thinks theat Th is worth at least 26 cents + the tax liability that goest with it.. lets rejoice on this festive news... and the market response is as usual a new low on dismal volume... now that we are priced in the Hersey bar territory and that we compare on PE basis to coal companies we can tell ourselves what this management has accomplished with their rocket science.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?